Peter Kies - Mar 8, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
CFO
Signature
Peter Kies
Stock symbol
INO
Transactions as of
Mar 8, 2022
Transactions value $
-$36,796
Form type
4
Date filed
3/9/2022, 03:08 PM
Previous filing
Mar 1, 2022
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +21.5K +15.25% 162K Mar 8, 2022 Direct F1
transaction INO Common Stock Tax liability -$36.8K -11.3K -6.96% $3.26* 151K Mar 8, 2022 Direct F2
holding INO Common Stock 4.5K Mar 8, 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -21.5K -100% $0.00* 0 Mar 8, 2022 Common Stock 21.5K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.